Patent Yard Sign in
Expired Canadian patentCanada

Derivatives of dihydroindenothiadiazinone

CA 1251205 A · Owner: Smith Kline & French Laboratories Limited · Inventors: Coates, William J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of the formula (I) :- (I), and salts thereof, wherein R1 is hydrogen C1-6alkyl, halo, cyano, nitro, amino, a group -NHCOR4 a group, -COR5, or a group -NHC(NCN)NHR6; wherein R4 is hydrogen, C1-6alkoxy, C1-6alkyl optionally substituted by phenyl, or R4 is a group NR7R8 wherein R7 and R8 are independently hydrogen, C1-6alkyl or benzyl; R5 is hydroxy, hydrogen, C1-6alkyl, C1-6alkoxy or a, group -NR7R8; and R6 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-4alkyl; R3 is hydrogen or C1-4alkyl; and n is one, and when R3 is hydrogen n can also be two. Processes and intermediates for their preparation are described. Pharmaceutical compositions containing them are described, as is their use …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted March 14, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 14, 2006.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 1, 1984
GrantedMarch 14, 1989
Term endedMarch 14, 2006
Patent numberCA 1251205 A
Classification (IPC)C07D285/16 +2 more

Timeline

Timeline From CIPO dates

19851988199119941997200020032006Application filedNov 1, 1984Patent grantedMarch 14, 1989Term endedMarch 14, 2006

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.